DERM Stock Earnings: Journey Medical Misses EPS, Beats Revenue for Q2 2024

    Date:

    Journey Medical (NASDAQ:DERM) just reported results for the second quarter of 2024.

    • Journey Medical reported earnings per share of -17 cents. This was below the analyst estimate for EPS of -14 cents.
    • The company reported revenue of $14.86 million.
    • This was 7.02% better than the analyst estimate for revenue of $13.88 million.

    InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

    Chart

    SignUp For Breaking Alerts

    New Graphic

    We respect your email privacy

    Share post:

    Popular

    More like this
    Related

    Volatility Slouches

    “Slouch” is very descriptive word.  As a noun it’s...

    PPI Reflects Uptick in Goods Charges: Nov. 14, 2024

    Investors are parsing through employment and inflation data while...

    Market Making for Beginners

    The article “Market Making for Beginners” first appeared on...

    Chart Advisor: One Chart to Rule’m All

    By Tom Bruni, CMT 1/ One Chart to Rule’m All 2/ AMD...